Vanguard Group Inc Orgenesis Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORGS
# of Institutions
16Shares Held
1.54MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA283KShares$339,6920.0% of portfolio
-
Black Rock Inc. New York, NY79.9KShares$95,8660.0% of portfolio
-
State Street Corp Boston, MA78.9KShares$94,6530.0% of portfolio
-
Ronit Capital LLP54.2KShares$65,0000.1% of portfolio
-
Northern Trust Corp Chicago, IL40.5KShares$48,6140.0% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $30.7M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...